Clinical trials in Skokie, IL

27 recruiting studies have a site in or near Skokie, IL, Illinois.

Top conditions here

All conditions

Showing 27 of 27 studies

RecruitingPhase 3NCT06345729

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Sponsor: Merck Sharp & Dohme LLC

Skokie, IL · +14 more sites

RecruitingPhase 2NCT07610473

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Sponsor: Draig Therapeutics Ltd

Chicago, IL · Skokie, IL · +21 more sites

RecruitingPhase 3NCT07816367

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Gurnee, IL · Skokie, IL · +70 more sites

RecruitingPhase 3NCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Sponsor: Novartis Pharmaceuticals

Skokie, IL · Willowbrook, IL · +23 more sites

RecruitingPhase 3NCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Sponsor: Bristol-Myers Squibb

Chicago, IL · Skokie, IL · +120 more sites

RecruitingPhase 1NCT07310420

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Sponsor: TerSera Therapeutics LLC

Chicago, IL · Evanston, IL · Lisle, IL · +23 more sites

RecruitingPhase 3NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Sponsor: Hoffmann-La Roche

Gurnee, IL · Schaumburg, IL · Skokie, IL · +41 more sites

RecruitingPhase 3NCT07595549

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Sponsor: Pfizer

Chicago, IL · Evanston, IL · +32 more sites

RecruitingPhase 2NCT07276581

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Sponsor: AstraZeneca

Skokie, IL · Willowbrook, IL · +27 more sites

RecruitingPhase 2NCT06972446

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Sponsor: AbbVie

Chicago, IL · Libertyville, IL · Orland Park, IL · +46 more sites

RecruitingPhase 2NCT06143956

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Sponsor: Eli Lilly and Company

Chicago, IL · Skokie, IL · +47 more sites

RecruitingPhase 3NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Sponsor: Amgen

Chicago, IL · Skokie, IL · +68 more sites

RecruitingPhase 3NCT07564414

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Sponsor: Novo Nordisk A/S

Chicago, IL · Gillespie, IL · Gurnee, IL · +96 more sites

RecruitingPhase 3NCT07668414

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Sponsor: Novo Nordisk A/S

Chicago, IL · Skokie, IL · +43 more sites

RecruitingPhase 3NCT06807424

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

Sponsor: Janssen Research & Development, LLC

Skokie, IL · +24 more sites

RecruitingPhase 3NCT07339423

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Sponsor: Novo Nordisk A/S

Skokie, IL · +21 more sites

RecruitingPhase 2NCT06797635

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Sponsor: Merck Sharp & Dohme LLC

Skokie, IL · +7 more sites

RecruitingPhase 3NCT06252649

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Sponsor: Amgen

Chicago, IL · Hinsdale, IL · Skokie, IL · +23 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Alton, IL · Aurora, IL · +1223 more sites

RecruitingPhase 3NCT07662109

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Chicago, IL · Skokie, IL · +38 more sites

RecruitingPhase 1 / Phase 2NCT06330064

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Sponsor: Daiichi Sankyo

Skokie, IL · +17 more sites

RecruitingPhase 2NCT06937177

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Sponsor: Endevica Bio

Chicago, IL · Hinsdale, IL · Skokie, IL · +22 more sites

RecruitingNot applicableNCT03887715

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Sponsor: LivaNova

Chicago, IL · Joliet, IL · Naperville, IL · +98 more sites

RecruitingPhase 2NCT06717698

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Sponsor: Novo Nordisk A/S

Skokie, IL · +17 more sites

RecruitingPhase 2NCT05806515

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Sponsor: SWOG Cancer Research Network

Evanston, IL · Glenview, IL · Highland Park, IL · +130 more sites

RecruitingPhase 2NCT06865105

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

Sponsor: AbbVie

Skokie, IL · Willowbrook, IL · +14 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Alton, IL · Aurora, IL · +952 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.